Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 8 (2011), Issue 1 (January)

1. Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania - Results of a two year observational study in bipolar disorder (EMBLEM).
   J Affect Disord. [Abstract] [Full-text]
2. Differences between bipolar I and bipolar II disorders in clinical features, comorbidity, and family history.
   J Affect Disord. [Abstract] [Full-text]
3. Histone deacetylases in skeletal development and bone mass maintenance.
   Gene. [Abstract] [Full-text]
4. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: Relevance to valproate's efficacy against bipolar disorder.
   Biochim Biophys Acta. [Abstract] [Full-text]
5. Psychotropic drug-related eosinophilia with systemic symptoms after acute caffeine ingestion.
   Pediatrics, 127(1): e235-8. [Abstract] [Full-text]
6. Brain metabolite concentrations across cortical regions in healthy adults.
   Brain Res, 1369: 89-94. [Abstract] [Full-text]
7. Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania - Results of a two year observational study in bipolar disorder (EMBLEM).
   J Affect Disord. [Abstract] [Full-text]
8. Differences between bipolar I and bipolar II disorders in clinical features, comorbidity, and family history.
   J Affect Disord. [Abstract] [Full-text]
9. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: Relevance to valproate's efficacy against bipolar disorder.
   Biochim Biophys Acta. [Abstract] [Full-text]
10. Psychotropic drug-related eosinophilia with systemic symptoms after acute caffeine ingestion.
    Pediatrics, 127(1): e235-8. [Abstract] [Full-text]
11. Brain metabolite concentrations across cortical regions in healthy adults.
    Brain Res, 1369: 89-94. [Abstract] [Full-text]
12. Elevated Delta-6 desaturase (FADS2) gene expression in the prefrontal cortex of patients with bipolar disorder.
    J Psychiatr Res, 45(2): 269-72. [Abstract] [Full-text]
13. Peripheral biomarkers and illness activity in bipolar disorder.
    J Psychiatr Res, 45(2): 156-61. [Abstract] [Full-text]
14. Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes.
    J Psychiatr Res, 45(2): 169-73. [Abstract] [Full-text]
15. Psychotropic drug-related eosinophilia with systemic symptoms after acute caffeine ingestion.
    Pediatrics, 127(1): e235-8. [Abstract] [Full-text]
16. Brain metabolite concentrations across cortical regions in healthy adults.
    Brain Res, 1369: 89-94. [Abstract] [Full-text]
17. Elevated Delta-6 desaturase (FADS2) gene expression in the prefrontal cortex of patients with bipolar disorder.
    J Psychiatr Res, 45(2): 269-72. [Abstract] [Full-text]
18. Peripheral biomarkers and illness activity in bipolar disorder.
    J Psychiatr Res, 45(2): 156-61. [Abstract] [Full-text]
19. Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes.
    J Psychiatr Res, 45(2): 169-73. [Abstract] [Full-text]
20. Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder.
    Proteomics, 11(2): 261-9. [Abstract] [Full-text]
21. Lithium Fails to Protect Dopaminergic Neurons in the 6-OHDA Model of Parkinson's Disease.
    Neurochem Res. [Abstract] [Full-text]
22. Risk of psychiatric treatment for mood disorders and psychotic disorders among migrants and Dutch nationals in Utrecht, The Netherlands.
    Soc Psychiatry Psychiatr Epidemiol. [Abstract] [Full-text]
23. Description of Study Population and Analysis of Factors Influencing Adherence in the Observational Italian Study "Evaluation of Pharmacotherapy Adherence in Bipolar Disorder" (EPHAR).
    CNS Neurosci Ther. [Abstract] [Full-text]
24. Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.
    Int J Clin Pract. [Abstract] [Full-text]
25. Functional SNPs in Genes Encoding the 5-HT2A Receptor Modify the Affinity and Potency of Several Atypical Antipsychotic Drugs.
    Biol Res Nurs, 13(1): 55-60. [Abstract] [Full-text]
26. Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder.
    Proteomics, 11(2): 261-9. [Abstract] [Full-text]
27. Lithium Fails to Protect Dopaminergic Neurons in the 6-OHDA Model of Parkinson's Disease.
    Neurochem Res. [Abstract] [Full-text]
28. Risk of psychiatric treatment for mood disorders and psychotic disorders among migrants and Dutch nationals in Utrecht, The Netherlands.
    Soc Psychiatry Psychiatr Epidemiol. [Abstract] [Full-text]
29. Description of Study Population and Analysis of Factors Influencing Adherence in the Observational Italian Study "Evaluation of Pharmacotherapy Adherence in Bipolar Disorder" (EPHAR).
    CNS Neurosci Ther. [Abstract] [Full-text]
30. Experience of living with a family member with bipolar disorder.
    Int J Ment Health Nurs, 20(1): 29-37. [Abstract] [Full-text]
31. Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.
    Int J Clin Pract. [Abstract] [Full-text]
32. Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs.
    Biol Res Nurs, 13(1): 55-60. [Abstract] [Full-text]
33. Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder.
    Proteomics, 11(2): 261-9. [Abstract] [Full-text]
34. Risk of psychiatric treatment for mood disorders and psychotic disorders among migrants and Dutch nationals in Utrecht, The Netherlands.
    Soc Psychiatry Psychiatr Epidemiol. [Abstract] [Full-text]
35. The missing p in psychiatric training: why it is important to teach pain to psychiatrists.
    Arch Gen Psychiatry, 68(1): 12-20. [Abstract] [Full-text]
36. Experience of living with a family member with bipolar disorder.
    Int J Ment Health Nurs, 20(1): 29-37. [Abstract] [Full-text]
37. Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs.
    Biol Res Nurs, 13(1): 55-60. [Abstract] [Full-text]
38. Cognitive functioning in severe psychiatric disorders: a general population study.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
39. Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample.
    Eur J Hum Genet. [Abstract] [Full-text]
40. Hypomania Induction in a Patient With Bipolar II Disorder by Transcranial Direct Current Stimulation (tDCS).
    J ECT. [Abstract] [Full-text]
41. Predictors of patient and caregiver distress in an adult sample with bipolar disorder seeking family treatment.
    J Nerv Ment Dis, 199(1): 18-24. [Abstract] [Full-text]
42. Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis.
    Int J Neuropsychopharmacol. [Abstract] [Full-text]
43. Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder.
    Am J Psychiatry, 168(1): 40-8. [Abstract] [Full-text]
44. Proposing an adaptive mutation to improve XCSF performance to classify ADHD and BMD patients.
    J Neural Eng, 7(6): 066006. [Abstract] [Full-text]
45. Cognitive functioning in severe psychiatric disorders: a general population study.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
46. Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample.
    Eur J Hum Genet. [Abstract] [Full-text]
47. Hypomania Induction in a Patient With Bipolar II Disorder by Transcranial Direct Current Stimulation (tDCS).
    J ECT. [Abstract] [Full-text]
48. Predictors of patient and caregiver distress in an adult sample with bipolar disorder seeking family treatment.
    J Nerv Ment Dis, 199(1): 18-24. [Abstract] [Full-text]
49. Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis.
    Int J Neuropsychopharmacol. [Abstract] [Full-text]
50. Update on chronic daily headache.
    Curr Treat Options Neurol, 13(1): 41-55. [Abstract] [Full-text]
51. Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder.
    Am J Psychiatry, 168(1): 40-8. [Abstract] [Full-text]
52. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder.
    Psychol Med, 41(2): 225-41. [Abstract] [Full-text]
53. Cognitive functioning in severe psychiatric disorders: a general population study.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
54. Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample.
    Eur J Hum Genet. [Abstract] [Full-text]
55. Hypomania Induction in a Patient With Bipolar II Disorder by Transcranial Direct Current Stimulation (tDCS).
    J ECT. [Abstract] [Full-text]
56. Predictors of patient and caregiver distress in an adult sample with bipolar disorder seeking family treatment.
    J Nerv Ment Dis, 199(1): 18-24. [Abstract] [Full-text]
57. Update on chronic daily headache.
    Curr Treat Options Neurol, 13(1): 41-55. [Abstract] [Full-text]
58. Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder.
    Am J Psychiatry, 168(1): 40-8. [Abstract] [Full-text]
59. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder.
    Psychol Med, 41(2): 225-41. [Abstract] [Full-text]
60. Migraine and psychiatric comorbidity: a review of clinical findings.
    J Headache Pain. [Abstract] [Full-text]
61. Employment Status of Patients in the VA Health System: Implications for Mental Health Services.
    Psychiatr Serv, 62(1): 35-8. [Abstract] [Full-text]
62. Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
    Int J Neuropsychopharmacol. [Abstract] [Full-text]
63. Study protocol: a randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders.
    BMC Public Health, 11(1): 10. [Abstract] [Full-text]
64. The lived experience of adults with bipolar disorder and comorbid substance use disorder.
    Issues Ment Health Nurs, 32(1): 20-7. [Abstract] [Full-text]
65. Migraine and psychiatric comorbidity: a review of clinical findings.
    J Headache Pain. [Abstract] [Full-text]
66. Employment status of patients in the VA health system: implications for mental health services.
    Psychiatr Serv, 62(1): 35-8. [Abstract] [Full-text]
67. Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
    Int J Neuropsychopharmacol. [Abstract] [Full-text]
68. The lived experience of adults with bipolar disorder and comorbid substance use disorder.
    Issues Ment Health Nurs, 32(1): 20-7. [Abstract] [Full-text]
69. Migraine and psychiatric comorbidity: a review of clinical findings.
    J Headache Pain. [Abstract] [Full-text]
70. Employment status of patients in the VA health system: implications for mental health services.
    Psychiatr Serv, 62(1): 35-8. [Abstract] [Full-text]
71. Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
    Int J Neuropsychopharmacol. [Abstract] [Full-text]
72. The lived experience of adults with bipolar disorder and comorbid substance use disorder.
    Issues Ment Health Nurs, 32(1): 20-7. [Abstract] [Full-text]
73. In silico study on the substrate binding manner in human myo-inositol monophosphatase 2.
    J Mol Model. [Abstract] [Full-text]
74. Screening for Malingering/Exaggeration of Psychiatric Symptomatology in Prison Inmates Using the PICTS Confusion and Infrequency Scales*
    J Forensic Sci. [Abstract] [Full-text]
75. Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: Evidence for a common genetic vulnerability?
    Brain Behav Immun. [Abstract] [Full-text]
76. In silico study on the substrate binding manner in human myo-inositol monophosphatase 2.
    J Mol Model. [Abstract] [Full-text]
77. Screening for Malingering/Exaggeration of Psychiatric Symptomatology in Prison Inmates Using the PICTS Confusion and Infrequency Scales*
    J Forensic Sci. [Abstract] [Full-text]
78. In silico study on the substrate binding manner in human myo-inositol monophosphatase 2.
    J Mol Model. [Abstract] [Full-text]
79. Screening for Malingering/Exaggeration of Psychiatric Symptomatology in Prison Inmates Using the PICTS Confusion and Infrequency Scales*
    J Forensic Sci. [Abstract] [Full-text]
80. Increasing off-label use of antipsychotic medications in the United States, 1995-2008.
    Pharmacoepidemiol Drug Saf. [Abstract] [Full-text]
81. Bilateral Rasmussen encephalitis.
    Epilepsy Behav. [Abstract] [Full-text]
82. Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA.
    Psychiatry Res. [Abstract] [Full-text]
83. Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11.2 deletion syndrome.
    J Affect Disord. [Abstract] [Full-text]
84. One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis.
    BMC Psychiatry, 11(1): 6. [Abstract] [Full-text]
85. Neuropsychological factors differentiating treated children with pediatric bipolar disorder from those with attention-deficit/hyperactivity disorder.
    J Clin Exp Neuropsychol, 33(1): 74-84. [Abstract] [Full-text]
86. Increasing off-label use of antipsychotic medications in the United States, 1995-2008.
    Pharmacoepidemiol Drug Saf. [Abstract] [Full-text]
87. Bilateral Rasmussen encephalitis.
    Epilepsy Behav. [Abstract] [Full-text]
88. Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA.
    Psychiatry Res. [Abstract] [Full-text]
89. Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11.2 deletion syndrome.
    J Affect Disord. [Abstract] [Full-text]
90. One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis.
    BMC Psychiatry, 11(1): 6. [Abstract] [Full-text]
91. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder.
    Neuropathol Appl Neurobiol, 37(2): 206-19. [Abstract] [Full-text]
92. Neuropsychological factors differentiating treated children with pediatric bipolar disorder from those with attention-deficit/hyperactivity disorder.
    J Clin Exp Neuropsychol, 33(1): 74-84. [Abstract] [Full-text]
93. Increasing off-label use of antipsychotic medications in the United States, 1995-2008.
    Pharmacoepidemiol Drug Saf. [Abstract] [Full-text]
94. Bilateral Rasmussen encephalitis.
    Epilepsy Behav. [Abstract] [Full-text]
95. Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA.
    Psychiatry Res. [Abstract] [Full-text]
96. Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11.2 deletion syndrome.
    J Affect Disord. [Abstract] [Full-text]
97. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder.
    Neuropathol Appl Neurobiol, 37(2): 206-19. [Abstract] [Full-text]
98. Neuropsychological factors differentiating treated children with pediatric bipolar disorder from those with attention-deficit/hyperactivity disorder.
    J Clin Exp Neuropsychol, 33(1): 74-84. [Abstract] [Full-text]
99. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
    J Affect Disord, 128: S21-S28. [Abstract] [Full-text]
100. Aripiprazole: A clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness.
     J Affect Disord, 128: S11-S20. [Abstract] [Full-text]
101. Association between median family income and self-reported mood symptoms in bipolar disorder.
     Compr Psychiatry, 52(1): 17-25. [Abstract] [Full-text]
102. Reproduction among 1975 Sardinian women and men diagnosed with major mood disorders.
     Acta Psychiatr Scand. [Abstract] [Full-text]
103. Real-world comparison of CPU and GPU implementations of SNPrank: a network analysis tool for GWAS.
     Bioinformatics, 27(2): 284-5. [Abstract] [Full-text]
104. A pilot study of antipsychotic prescribing decisions for acutely-Ill hospitalized patients.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 246-51. [Abstract] [Full-text]
105. The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 184-97. [Abstract] [Full-text]
106. Neuropsychological functions in Han Chinese patients in Taiwan with bipolar II disorder comorbid and not comorbid with alcohol abuse/alcohol dependence disorder.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 131-6. [Abstract] [Full-text]
107. Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 96-101. [Abstract] [Full-text]
108. The role of Wnt signaling and its interaction with diverse mechanisms of cellular apoptosis in the pathophysiology of bipolar disorder.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 11-7. [Abstract] [Full-text]
109. Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder.
     J Psychiatr Res, 45(1): 54-9. [Abstract] [Full-text]
110. MicroRNA-134 plasma levels before and after treatment for bipolar mania.
     J Psychiatr Res, 45(1): 92-5. [Abstract] [Full-text]
111. Heart disease treatment and mortality in schizophrenia and bipolar disorder - Changes in the danish population between 1994 and 2006.
     J Psychiatr Res, 45(1): 29-35. [Abstract] [Full-text]
112. White matter hyperintensities in affected and unaffected late teenage and early adulthood offspring of bipolar parents: A two-center high-risk study.
     J Psychiatr Res, 45(1): 76-82. [Abstract] [Full-text]
113. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
     J Affect Disord, 128: S21-8. [Abstract] [Full-text]
114. Aripiprazole: A clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness.
     J Affect Disord, 128: S11-20. [Abstract] [Full-text]
115. Association between median family income and self-reported mood symptoms in bipolar disorder.
     Compr Psychiatry, 52(1): 17-25. [Abstract] [Full-text]
116. Usefulness of the Mini Nutritional Assessment (MNA) in predicting the nutritional status of people with mental disorders in Taiwan.
     J Clin Nurs, 20(3): 341-50. [Abstract] [Full-text]
117. Reproduction among 1975 Sardinian women and men diagnosed with major mood disorders.
     Acta Psychiatr Scand. [Abstract] [Full-text]
118. Real-world comparison of CPU and GPU implementations of SNPrank: a network analysis tool for GWAS.
     Bioinformatics, 27(2): 284-5. [Abstract] [Full-text]
119. A pilot study of antipsychotic prescribing decisions for acutely-Ill hospitalized patients.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 246-51. [Abstract] [Full-text]
120. The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 184-97. [Abstract] [Full-text]
121. Neuropsychological functions in Han Chinese patients in Taiwan with bipolar II disorder comorbid and not comorbid with alcohol abuse/alcohol dependence disorder.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 131-6. [Abstract] [Full-text]
122. Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 96-101. [Abstract] [Full-text]
123. The role of Wnt signaling and its interaction with diverse mechanisms of cellular apoptosis in the pathophysiology of bipolar disorder.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 11-7. [Abstract] [Full-text]
124. Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder.
     J Psychiatr Res, 45(1): 54-9. [Abstract] [Full-text]
125. MicroRNA-134 plasma levels before and after treatment for bipolar mania.
     J Psychiatr Res, 45(1): 92-5. [Abstract] [Full-text]
126. Heart disease treatment and mortality in schizophrenia and bipolar disorder - changes in the Danish population between 1994 and 2006.
     J Psychiatr Res, 45(1): 29-35. [Abstract] [Full-text]
127. White matter hyperintensities in affected and unaffected late teenage and early adulthood offspring of bipolar parents: a two-center high-risk study.
     J Psychiatr Res, 45(1): 76-82. [Abstract] [Full-text]
128. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
     J Affect Disord, 128: S21-8. [Abstract] [Full-text]
129. Aripiprazole: A clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness.
     J Affect Disord, 128: S11-20. [Abstract] [Full-text]
130. Association between median family income and self-reported mood symptoms in bipolar disorder.
     Compr Psychiatry, 52(1): 17-25. [Abstract] [Full-text]
131. Usefulness of the Mini Nutritional Assessment (MNA) in predicting the nutritional status of people with mental disorders in Taiwan.
     J Clin Nurs, 20(3): 341-50. [Abstract] [Full-text]
132. Reproduction among 1975 Sardinian women and men diagnosed with major mood disorders.
     Acta Psychiatr Scand. [Abstract] [Full-text]
133. Real-world comparison of CPU and GPU implementations of SNPrank: a network analysis tool for GWAS.
     Bioinformatics, 27(2): 284-5. [Abstract] [Full-text]
134. A pilot study of antipsychotic prescribing decisions for acutely-Ill hospitalized patients.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 246-51. [Abstract] [Full-text]
135. The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 184-97. [Abstract] [Full-text]
136. Neuropsychological functions in Han Chinese patients in Taiwan with bipolar II disorder comorbid and not comorbid with alcohol abuse/alcohol dependence disorder.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 131-6. [Abstract] [Full-text]
137. Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 96-101. [Abstract] [Full-text]
138. The role of Wnt signaling and its interaction with diverse mechanisms of cellular apoptosis in the pathophysiology of bipolar disorder.
     Prog Neuropsychopharmacol Biol Psychiatry, 35(1): 11-7. [Abstract] [Full-text]
139. Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder.
     J Psychiatr Res, 45(1): 54-9. [Abstract] [Full-text]
140. MicroRNA-134 plasma levels before and after treatment for bipolar mania.
     J Psychiatr Res, 45(1): 92-5. [Abstract] [Full-text]
141. Heart disease treatment and mortality in schizophrenia and bipolar disorder - changes in the Danish population between 1994 and 2006.
     J Psychiatr Res, 45(1): 29-35. [Abstract] [Full-text]
142. White matter hyperintensities in affected and unaffected late teenage and early adulthood offspring of bipolar parents: a two-center high-risk study.
     J Psychiatr Res, 45(1): 76-82. [Abstract] [Full-text]
143. Regulation of α₂-adrenoceptor gene expression by chronic lithium treatment in rat brain.
     Methods Find Exp Clin Pharmacol, 32(10): 721-5. [Abstract] [Full-text]
144. Decreased BDNF, trkB-TK+ and GAD(67) mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.
     J Psychiatry Neurosci. [Abstract] [Full-text]
145. Differences in temperament and character dimensions in patients with bipolar I or II or major depressive disorder and general population subjects.
     Psychol Med. [Abstract] [Full-text]
146. Differences in temperament and character dimensions in patients with bipolar I or II or major depressive disorder and general population subjects.
     Psychol Med. [Abstract] [Full-text]
147. Differences in temperament and character dimensions in patients with bipolar I or II or major depressive disorder and general population subjects.
     Psychol Med. [Abstract] [Full-text]
148. GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders.
     Int J Neuropsychopharmacol. [Abstract] [Full-text]
149. GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders.
     Int J Neuropsychopharmacol. [Abstract] [Full-text]
150. GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders.
     Int J Neuropsychopharmacol. [Abstract] [Full-text]
151. Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population.
     Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
152. Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder.
     Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
153. Association of ANK3 with bipolar disorder confirmed in East Asia.
     Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
154. Genetic variants in the ErbB4 gene are associated with white matter integrity.
     Psychiatry Res. [Abstract] [Full-text]
155. Regulation of cell cycle and DNA repair in post-mitotic GABA neurons in psychotic disorders.
     Neuropharmacology. [Abstract] [Full-text]
156. Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population.
     Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
157. Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder.
     Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
158. Association of ANK3 with bipolar disorder confirmed in East Asia.
     Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
159. Regulation of cell cycle and DNA repair in post-mitotic GABA neurons in psychotic disorders.
     Neuropharmacology. [Abstract] [Full-text]
160. The Child Behavior Checklist-Dysregulation Profile predicts substance use, suicidality, and functional impairment: a longitudinal analysis.
     J Child Psychol Psychiatry, 52(2): 139-47. [Abstract] [Full-text]
161. Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population.
     Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
162. Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder.
     Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
163. Association of ANK3 with bipolar disorder confirmed in East Asia.
     Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
164. The Child Behavior Checklist-Dysregulation Profile predicts substance use, suicidality, and functional impairment: a longitudinal analysis.
     J Child Psychol Psychiatry, 52(2): 139-47. [Abstract] [Full-text]
165. Abnormal frontal cortex white matter connections in bipolar disorder: A DTI tractography study.
     J Affect Disord. [Abstract] [Full-text]
166. Histone deacetylases in skeletal development and bone mass maintenance.
     Gene. [Abstract] [Full-text]
167. Abnormal frontal cortex white matter connections in bipolar disorder: A DTI tractography study.
     J Affect Disord. [Abstract] [Full-text]
168. Hemiarthroplasty in a patient with severe systemic sclerosis.
     Clin Rheumatol. [Abstract] [Full-text]
169. Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications.
     Clin Neuropharmacol, 34(1): 39-47. [Abstract] [Full-text]
170. Trace elements in bipolar disorder.
     J Trace Elem Med Biol. [Abstract] [Full-text]
171. The effect of processing speed on cognitive functioning in patients with familial bipolar I disorder and their unaffected relatives.
     Psychopathology, 44(1): 40-5. [Abstract] [Full-text]
172. Differential responses to emotional interference in paranoid schizophrenia and bipolar mania.
     Psychopathology, 44(1): 1-11. [Abstract] [Full-text]
173. Hemiarthroplasty in a patient with severe systemic sclerosis.
     Clin Rheumatol. [Abstract] [Full-text]
174. Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications.
     Clin Neuropharmacol, 34(1): 39-47. [Abstract] [Full-text]
175. Trace elements in bipolar disorder.
     J Trace Elem Med Biol. [Abstract] [Full-text]
176. The effect of processing speed on cognitive functioning in patients with familial bipolar I disorder and their unaffected relatives.
     Psychopathology, 44(1): 40-5. [Abstract] [Full-text]
177. Differential responses to emotional interference in paranoid schizophrenia and bipolar mania.
     Psychopathology, 44(1): 1-11. [Abstract] [Full-text]
178. Suicidality and divalproex sodium: analysis of controlled studies in multiple indications.
     Ann Gen Psychiatry, 10(1): 1. [Abstract] [Full-text]
179. Common promoter variants of the NDUFV2 gene do not confer susceptibility to schizophrenia in Han Chinese.
     Behav Brain Funct, 6: 75. [Abstract] [Full-text]
180. Electroconvulsive therapy for psychotropic-refractory bipolar affective disorder and severe self-injury and aggression in an 11-year-old autistic boy.
     Eur Child Adolesc Psychiatry. [Abstract] [Full-text]
181. Lithium Use and Primary Hyperparathyroidism.
     Endocr Pract. [Abstract] [Full-text]
182. Common SNPs in CSF2RB are associated with major depression and schizophrenia in the Chinese Han population.
     World J Biol Psychiatry. [Abstract] [Full-text]
183. Electroconvulsive therapy for psychotropic-refractory bipolar affective disorder and severe self-injury and aggression in an 11-year-old autistic boy.
     Eur Child Adolesc Psychiatry. [Abstract] [Full-text]
184. Lithium Use and Primary Hyperparathyroidism.
     Endocr Pract. [Abstract] [Full-text]
185. Common SNPs in CSF2RB are associated with major depression and schizophrenia in the Chinese Han population.
     World J Biol Psychiatry. [Abstract] [Full-text]
186. Increasing off-label use of antipsychotic medications in the United States, 1995-2008.
     Pharmacoepidemiol Drug Saf, 20(2): 177-84. [Abstract] [Full-text]
187. Propensity score-based nonparametric test revealing genetic variants underlying bipolar disorder.
     Genet Epidemiol, 35(2): 125-32. [Abstract] [Full-text]
188. Lithium in Drinking Water and Thyroid Function.
     Environ Health Perspect. [Abstract] [Full-text]
189. Reliability and validity of the chinese version of the mood disorder questionnaire.
     Arch Psychiatr Nurs, 25(1): 53-62. [Abstract] [Full-text]
190. The Farsi version of the Hypomania Check-List 32 (HCL-32): Applicability and indication of a four-factorial solution.
     BMC Psychiatry, 11(1): 14. [Abstract] [Full-text]
191. Increasing off-label use of antipsychotic medications in the United States, 1995-2008.
     Pharmacoepidemiol Drug Saf, 20(2): 177-84. [Abstract] [Full-text]
192. Propensity score-based nonparametric test revealing genetic variants underlying bipolar disorder.
     Genet Epidemiol, 35(2): 125-32. [Abstract] [Full-text]
193. Lithium in Drinking Water and Thyroid Function.
     Environ Health Perspect. [Abstract] [Full-text]
194. Reliability and validity of the Chinese Version of the Mood Disorder Questionnaire.
     Arch Psychiatr Nurs, 25(1): 53-62. [Abstract] [Full-text]
195. HIV-1 seroprevalence and risk factors for HIV infection among first-time psychiatric admissions in Uganda.
     AIDS Care, 23(2): 171-8. [Abstract] [Full-text]
196. SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR AND CLOZAPINE DAILY DOSE IN PATIENTS WITH SCHIZOPHRENIA: A POSITIVE CORRELATION.
     Neurosci Lett. [Abstract] [Full-text]
197. Intensive high-frequency repetitive transcranial magnetic stimulation treatment in an electroconvulsive shock therapy-resistant bipolar I patient with mixed episode.
     Brain Stimul, 4(1): 46-9. [Abstract] [Full-text]
198. Aripiprazole for the treatment of bipolar disorder: a review of current evidence.
     Expert Opin Pharmacother, 12(3): 473-88. [Abstract] [Full-text]
199. Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data.
     CNS Drugs, 25(2): 109-27. [Abstract] [Full-text]
200. Decreased BDNF, trkB-TK+ and GAD(67) mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.
     J Psychiatry Neurosci, 36(1). [Abstract] [Full-text]
201. Study protocol: a randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders.
     BMC Public Health, 11(1): 10. [Abstract] [Full-text]
202. Downregulation of the cAMP/PKA Pathway in PC12 Cells Overexpressing NCS-1.
     Cell Mol Neurobiol, 31(1): 135-43. [Abstract] [Full-text]
203. Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder.
     J Affect Disord, 128(3): 305-8. [Abstract] [Full-text]
204. Three studies on self-report scales to detect bipolar disorder.
     J Affect Disord, 128(3): 199-210. [Abstract] [Full-text]
205. Painting "mania".
     J Affect Disord, 128(3): 319-20. [Abstract] [Full-text]
206. Prevalence and correlates of eating disorders in 875 patients with bipolar disorder.
     J Affect Disord, 128(3): 191-8. [Abstract] [Full-text]
207. The Hypomania Checklist-32 and the Mood Disorder Questionnaire as screening tools - going beyond samples of purely mood-disordered patients.
     J Affect Disord, 128(3): 291-8. [Abstract] [Full-text]
208. Positive aspects of mental illness: A review in bipolar disorder.
     J Affect Disord, 128(3): 185-90. [Abstract] [Full-text]
209. HIV-1 seroprevalence and risk factors for HIV infection among first-time psychiatric admissions in Uganda.
     AIDS Care, 23(2): 171-8. [Abstract] [Full-text]
210. Intensive high-frequency repetitive transcranial magnetic stimulation treatment in an electroconvulsive shock therapy-resistant bipolar I patient with mixed episode.
     Brain Stimul, 4(1): 46-9. [Abstract] [Full-text]
211. Aripiprazole for the treatment of bipolar disorder: a review of current evidence.
     Expert Opin Pharmacother, 12(3): 473-88. [Abstract] [Full-text]
212. Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data.
     CNS Drugs, 25(2): 109-27. [Abstract] [Full-text]
213. Study protocol: a randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders.
     BMC Public Health, 11(1): 10. [Abstract] [Full-text]
214. Downregulation of the cAMP/PKA Pathway in PC12 Cells Overexpressing NCS-1.
     Cell Mol Neurobiol, 31(1): 135-43. [Abstract] [Full-text]
215. Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder.
     J Affect Disord, 128(3): 305-8. [Abstract] [Full-text]
216. Three studies on self-report scales to detect bipolar disorder.
     J Affect Disord, 128(3): 199-210. [Abstract] [Full-text]
217. Painting "mania".
     J Affect Disord, 128(3): 319-20. [Abstract] [Full-text]
218. Prevalence and correlates of eating disorders in 875 patients with bipolar disorder.
     J Affect Disord, 128(3): 191-8. [Abstract] [Full-text]
219. The Hypomania Checklist-32 and the Mood Disorder Questionnaire as screening tools--going beyond samples of purely mood-disordered patients.
     J Affect Disord, 128(3): 291-8. [Abstract] [Full-text]
220. Positive aspects of mental illness: a review in bipolar disorder.
     J Affect Disord, 128(3): 185-90. [Abstract] [Full-text]
221. Hierarchical temporal processing deficit model of reality distortion and psychoses.
     Mol Psychiatry, 16(2): 129-44. [Abstract] [Full-text]
222. The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample.
     J Psychosom Res, 70(2): 145-54. [Abstract] [Full-text]
223. Genome-wide association study of recurrent early-onset major depressive disorder.
     Mol Psychiatry, 16(2): 193-201. [Abstract] [Full-text]
224. Hierarchical temporal processing deficit model of reality distortion and psychoses.
     Mol Psychiatry, 16(2): 129-44. [Abstract] [Full-text]
225. The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample.
     J Psychosom Res, 70(2): 145-54. [Abstract] [Full-text]
226. Genome-wide association study of recurrent early-onset major depressive disorder.
     Mol Psychiatry, 16(2): 193-201. [Abstract] [Full-text]
227. Decreasing the minimum length criterion for an episode of hypomania: evaluation using self-reported data from patients with bipolar disorder.
     Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
228. Excessive cannabis use is associated with earlier age at onset in bipolar disorder.
     Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
229. Reduced rate of neural differentiation in the dentate gyrus of adult dysbindin null (sandy) mouse.
     PLoS One, 6(1): e15886. [Abstract] [Full-text]
230. Improving treatment adherence in patients with bipolar disorder and substance abuse: rationale and initial development of a novel psychosocial approach.
     J Psychiatr Pract, 17(1): 5-20. [Abstract] [Full-text]
231. A high-throughput DNA methylation analysis of a single cell.
     Nucleic Acids Res. [Abstract] [Full-text]
232. Endoplasmic reticulum stress in brain damage.
     Methods Enzymol, 489: 259-75. [Abstract] [Full-text]
233. Age-specific prevalence of metabolic syndrome in Italian patients with bipolar disorder.
     Psychiatry Clin Neurosci, 65(1): 47-54. [Abstract] [Full-text]
234. Decreasing the minimum length criterion for an episode of hypomania: evaluation using self-reported data from patients with bipolar disorder.
     Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
235. Excessive cannabis use is associated with earlier age at onset in bipolar disorder.
     Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
236. Reduced rate of neural differentiation in the dentate gyrus of adult dysbindin null (sandy) mouse.
     PLoS One, 6(1): e15886. [Abstract] [Full-text]
237. Improving treatment adherence in patients with bipolar disorder and substance abuse: rationale and initial development of a novel psychosocial approach.
     J Psychiatr Pract, 17(1): 5-20. [Abstract] [Full-text]
238. A high-throughput DNA methylation analysis of a single cell.
     Nucleic Acids Res. [Abstract] [Full-text]
239. Endoplasmic reticulum stress in brain damage.
     Methods Enzymol, 489: 259-75. [Abstract] [Full-text]
240. Age-specific prevalence of metabolic syndrome in Italian patients with bipolar disorder.
     Psychiatry Clin Neurosci, 65(1): 47-54. [Abstract] [Full-text]
241. Are bipolar II patients cognitively impaired? A systematic review.
     Psychol Med. [Abstract] [Full-text]
242. Exploring the relationship between vitamin D and basic personality traits.
     Psychopharmacology (Berl). [Abstract] [Full-text]
243. Alternatives to antidepressants in treating acute bipolar depression.
     J Clin Psychiatry, 72(1): e03. [Abstract] [Full-text]
244. Developing an online psychoeducation package for bipolar disorder.
     J Ment Health, 20(1): 21-31. [Abstract] [Full-text]
245. Memantine reduces mania-like symptoms in animal models.
     Psychiatry Res. [Abstract] [Full-text]
246. Family history of psychiatric disorders and the outcome of psychiatric patients with DSM-IV major depressive disorder.
     J Affect Disord. [Abstract] [Full-text]
247. Comorbidities of epilepsy: Results from the Epilepsy Comorbidities and Health (EPIC) Survey.
     Epilepsia. [Abstract] [Full-text]
248. Voxel-based morphometric analysis on the volume of gray matter in bipolar I disorder.
     Psychiatry Res, 191(2): 92-7. [Abstract] [Full-text]
249. Genetic variants in the ErbB4 gene are associated with white matter integrity.
     Psychiatry Res, 191(2): 133-7. [Abstract] [Full-text]
250. Treating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: a review.
     J Clin Psychiatry, 72(1): 81-90. [Abstract] [Full-text]
251. Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: Evidence for a common genetic vulnerability?
     Brain Behav Immun. [Abstract] [Full-text]
252. Gene Expression and Genetic Variation Data Implicate PCLO in Bipolar Disorder.
     Biol Psychiatry, 69(4): 353-9. [Abstract] [Full-text]
253. The Bcl-2 Gene Polymorphism rs956572AA Increases Inositol 1,4,5-Trisphosphate Receptor-Mediated Endoplasmic Reticulum Calcium Release in Subjects with Bipolar Disorder.
     Biol Psychiatry, 69(4): 344-52. [Abstract] [Full-text]
254. Molecular pharmacology in a simple model system: Implicating MAP kinase and phosphoinositide signalling in bipolar disorder.
     Semin Cell Dev Biol, 22(1): 105-13. [Abstract] [Full-text]
255. Comparison of Antidepressant Responses in Patients with Bipolar vs. Unipolar Depression: A Meta-Analytic Review.
     Pharmacopsychiatry, 44(1): 21-6. [Abstract] [Full-text]
256. A morphometric analysis of the septal nuclei in schizophrenia and affective disorders: reduced neuronal density in the lateral septal nucleus in bipolar disorder.
     Eur Arch Psychiatry Clin Neurosci, 261(1): 47-58. [Abstract] [Full-text]
257. The effect of Li(+) on GSK-3 inhibition: Molecular dynamics simulation.
     J Mol Model, 17(2): 377-81. [Abstract] [Full-text]
258. Are bipolar II patients cognitively impaired? A systematic review.
     Psychol Med. [Abstract] [Full-text]
259. Exploring the relationship between vitamin D and basic personality traits.
     Psychopharmacology (Berl). [Abstract] [Full-text]
260. Alternatives to antidepressants in treating acute bipolar depression.
     J Clin Psychiatry, 72(1): e03. [Abstract] [Full-text]
261. Developing an online psychoeducation package for bipolar disorder.
     J Ment Health, 20(1): 21-31. [Abstract] [Full-text]
262. Memantine reduces mania-like symptoms in animal models.
     Psychiatry Res. [Abstract] [Full-text]
263. Family history of psychiatric disorders and the outcome of psychiatric patients with DSM-IV major depressive disorder.
     J Affect Disord. [Abstract] [Full-text]
264. Voxel-based morphometric analysis on the volume of gray matter in bipolar I disorder.
     Psychiatry Res, 191(2): 92-7. [Abstract] [Full-text]
265. Genetic variants in the ErbB4 gene are associated with white matter integrity.
     Psychiatry Res, 191(2): 133-7. [Abstract] [Full-text]
266. Treating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: a review.
     J Clin Psychiatry, 72(1): 81-90. [Abstract] [Full-text]
267. Gene Expression and Genetic Variation Data Implicate PCLO in Bipolar Disorder.
     Biol Psychiatry, 69(4): 353-9. [Abstract] [Full-text]
268. The Bcl-2 Gene Polymorphism rs956572AA Increases Inositol 1,4,5-Trisphosphate Receptor-Mediated Endoplasmic Reticulum Calcium Release in Subjects with Bipolar Disorder.
     Biol Psychiatry, 69(4): 344-52. [Abstract] [Full-text]
269. Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study.
     Biol Psychiatry, 69(4): 336-43. [Abstract] [Full-text]
270. Molecular pharmacology in a simple model system: Implicating MAP kinase and phosphoinositide signalling in bipolar disorder.
     Semin Cell Dev Biol, 22(1): 105-13. [Abstract] [Full-text]
271. Functional magnetic resonance imaging brain activation in bipolar mania: evidence for disruption of the ventrolateral prefrontal-amygdala emotional pathway.
     Biol Psychiatry, 69(4): 381-8. [Abstract] [Full-text]
272. Comparison of Antidepressant Responses in Patients with Bipolar vs. Unipolar Depression: A Meta-Analytic Review.
     Pharmacopsychiatry, 44(1): 21-6. [Abstract] [Full-text]
273. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data.
     Biol Psychiatry, 69(4): 326-35. [Abstract] [Full-text]
274. Disruption of white matter integrity in bipolar depression as a possible structural marker of illness.
     Biol Psychiatry, 69(4): 309-17. [Abstract] [Full-text]
275. A morphometric analysis of the septal nuclei in schizophrenia and affective disorders: reduced neuronal density in the lateral septal nucleus in bipolar disorder.
     Eur Arch Psychiatry Clin Neurosci, 261(1): 47-58. [Abstract] [Full-text]
276. The effect of Li(+) on GSK-3 inhibition: Molecular dynamics simulation.
     J Mol Model, 17(2): 377-81. [Abstract] [Full-text]
277. Voxel-based morphometric analysis on the volume of gray matter in bipolar I disorder.
     Psychiatry Res, 191(2): 92-7. [Abstract] [Full-text]
278. Genetic variants in the ErbB4 gene are associated with white matter integrity.
     Psychiatry Res, 191(2): 133-7. [Abstract] [Full-text]
279. Gene expression and genetic variation data implicate PCLO in bipolar disorder.
     Biol Psychiatry, 69(4): 353-9. [Abstract] [Full-text]
280. The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder.
     Biol Psychiatry, 69(4): 344-52. [Abstract] [Full-text]
281. Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study.
     Biol Psychiatry, 69(4): 336-43. [Abstract] [Full-text]
282. Functional magnetic resonance imaging brain activation in bipolar mania: evidence for disruption of the ventrolateral prefrontal-amygdala emotional pathway.
     Biol Psychiatry, 69(4): 381-8. [Abstract] [Full-text]
283. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data.
     Biol Psychiatry, 69(4): 326-35. [Abstract] [Full-text]
284. Disruption of white matter integrity in bipolar depression as a possible structural marker of illness.
     Biol Psychiatry, 69(4): 309-17. [Abstract] [Full-text]
285. Voxel-based morphometric analysis on the volume of gray matter in bipolar I disorder.
     Psychiatry Res, 191(2): 92-7. [Abstract] [Full-text]
286. Genetic variants in the ErbB4 gene are associated with white matter integrity.
     Psychiatry Res, 191(2): 133-7. [Abstract] [Full-text]
287. Quantitative proteomics for investigating psychiatric disorders.
     Proteomics Clin Appl, 5(1): 38-49. [Abstract] [Full-text]
288. Recoding past experiences: a qualitative study of how patients and family members adjust to the diagnosis of bipolar disorder.
     J Nerv Ment Dis, 199(2): 136-9. [Abstract] [Full-text]
289. Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder.
     BMC Psychiatry, 11(1): 18. [Abstract] [Full-text]
290. Bipolar disorder risk alleles in adult ADHD patients.
     Genes Brain Behav. [Abstract] [Full-text]
291. Is cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder?
     Schizophr Res, 125(2): 291-4. [Abstract] [Full-text]
292. The MDGA1 gene confers risk to schizophrenia and bipolar disorder.
     Schizophr Res, 125(2): 194-200. [Abstract] [Full-text]
293. Quantitative proteomics for investigating psychiatric disorders.
     Proteomics Clin Appl, 5(1): 38-49. [Abstract] [Full-text]
294. Recoding past experiences: a qualitative study of how patients and family members adjust to the diagnosis of bipolar disorder.
     J Nerv Ment Dis, 199(2): 136-9. [Abstract] [Full-text]
295. Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder.
     BMC Psychiatry, 11(1): 18. [Abstract] [Full-text]
296. Bipolar disorder risk alleles in adult ADHD patients.
     Genes Brain Behav. [Abstract] [Full-text]
297. Is cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder?
     Schizophr Res, 125(2): 291-4. [Abstract] [Full-text]
298. The MDGA1 gene confers risk to schizophrenia and bipolar disorder.
     Schizophr Res, 125(2): 194-200. [Abstract] [Full-text]
299. Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany.
     Int Clin Psychopharmacol, 26(2): 96-106. [Abstract] [Full-text]
300. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
     Int Clin Psychopharmacol, 26(2): 88-95. [Abstract] [Full-text]
301. Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany.
     Int Clin Psychopharmacol, 26(2): 96-106. [Abstract] [Full-text]
302. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
     Int Clin Psychopharmacol, 26(2): 88-95. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.